| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |